RAGE Signalling in Acute Inflammatory Disorders: Therapeutic Potential of Natural Products
Open Access
- 23 June 2026
- journal article
- review article
- Published by MDPI AG in Biomolecules
- Vol. 16 (7) , 929
Abstract
Acute inflammatory disorders, including acute lung injury, acute pancreatitis, ischaemia–reperfusion injury, and sepsis, are major clinical challenges characterised by rapid progression, a characteristic cytokine storm, and high mortality rates. The receptor for advanced glycation end-products (RAGE) serves as a pivotal multi-ligand pattern recognition receptor that integrates PAMPs and DAMPs. Excessive RAGE engagement triggers detrimental signalling cascades, notably NF-κB and MAPKs, which exacerbate hyperinflammation and lead to progressive organ dysfunction. Consequently, the RAGE axis represents a potent therapeutic target for mitigating hyperinflammation and improving clinical outcomes in acute inflammatory disorders. While initial pharmacological efforts focused on synthetic inhibitors and biologics, there is a shifting focus toward bioactive alternatives with high safety profiles. Here, we present recent molecular insights into RAGE-mediated pathogenesis in acute inflammatory disorders and evaluate current therapeutic strategies. Furthermore, we emphatically summarise the bioactive natural products, including terpenoids, flavonoids, alkaloids, and a xanthone, that prevent and treat acute inflammatory disorders by disrupting RAGE–ligand interactions and suppressing downstream oxidative stress and cytokine release. Integrating these molecular mechanisms with the pharmacological profiling of natural RAGE modulators provides a robust foundation for the development of next-generation therapeutic strategies to improve clinical outcomes in acute inflammatory disorders.Keywords
Funding Information
- National Natural Science Foundation of China (82574803)
- National Natural Science Foundation of China (81800575)
- National Natural Science Foundation of China (82270672)
- Science and Technology Department of Sichuan Province (2022YFS0419)
This publication has 187 references indexed in Scilit:
- Oxymatrine attenuates sepsis‐induced inflammation and organ injury via inhibition of HMGB1/RAGE/NF‐κB signaling pathwayDrug Development Research, 2024
- Differential gene expression analysis of RAGE‐S100A6 complex for target selection and the design of novel inhibitors for anticancer drug discoveryJournal of Cellular Biochemistry, 2022
- The HMGB1-RAGE axis induces apoptosis in acute respiratory distress syndrome through PERK/eIF2α/ATF4-mediated endoplasmic reticulum stressInflammation Research, 2022
- Mortality in acute pancreatitis with persistent organ failure is determined by the number, type, and sequence of organ systems affectedUnited European Gastroenterology Journal, 2021
- RAGE blockade and hepatic microcirculation in experimental endotoxaemic liver failureBritish Journal of Surgery, 2013
- Ectodomain shedding of the receptor for advanced glycation end products: a novel therapeutic target for Alzheimer’s diseaseCellular and Molecular Life Sciences, 2009
- Circulating Levels of Soluble Receptor for Advanced Glycation End Products in Alzheimer Disease and Vascular DementiaArchives of Neurology, 2005
- Characterization of a novel EGFP reporter mouse to monitor Cre recombination as demonstrated by a Tie2 Cre mouse lineGenesis, 2001
- Role of receptor for advanced glycation end-product (RAGE) and the JAK/STAT-signaling pathway in AGE-induced collagen production in NRK-49F cellsJournal of Cellular Biochemistry, 2001
- Type II Alveolar Epithelial Cells in Lung Express Receptor for Advanced Glycation End Products (RAGE) GeneBiochemical and Biophysical Research Communications, 1997